Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 5—May 2020
Synopsis

Mosquito Control Activities during Local Transmission of Zika Virus, Miami-Dade County, Florida, USA, 2016

Janet C. McAllisterComments to Author , Mario Porcelli, Johana M. Medina, Mark J. Delorey, C. Roxanne Connelly1, Marvin S. Godsey, Nicholas A. Panella, Nicole Dzuris, Karen A. Boegler, Joan L. Kenney, Linda Kothera, Lucrecia Vizcaino, Audrey E. Lenhart, John-Paul Mutebi, and Chalmers Vasquez
Author affiliations: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (J.C. McAllister, M.J. Delorey, M.S. Godsey, N.A. Panella, K.A. Boegler, J.L. Kenney, L. Kothera, J.-P. Mutebi); Miami-Dade County Mosquito Control Division, Miami, Florida, USA (M. Porcelli, J.M. Medina, C. Vasquez); Florida Medical Entomology Laboratory, Vero Beach, Florida, USA (C.R. Connelly); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (N. Dzuris, L. Vizcaino, A.E. Lenhart)

Main Article

Table 2

Percentages of mosquito populations susceptible to active ingredients or products used for adult mosquito control in laboratory bioassays and field tests of Aedes aegypti mosquitoes, Miami-Dade County, Florida, USA, 2016*

Chemical/product Bottle dosage, μg/bottle Mosquito death, %
CDC bottle bioassay At 1/2 label rate in field assay At full label rate in field assay
Naled† 2.25 100 NA NA
Malathion† 400 100 NA NA
Deltamethrin/DeltaGard‡ 0.75 5–65 80 93
Etofenprox/Zenivex§ 12.5 1–7 19 57
Permethrin/Biomist¶ 43 2–12 33 NA
Sumithrin/Duet¶ 20 3–14 44 NA

*NA, test not conducted because mosquitoes were susceptible to active ingredient or field test results excluded it from further testing.
†Used in bottle bioassays only. No field tests were conducted because mosquitoes were susceptible to this chemical.
‡Bayer CropScience LP, https://www.bayer.com.
§Wellmark International, https://www.bpia.org.
¶Clarke, https://www.clarke.com.

Main Article

1Current affiliation. Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Page created: April 15, 2020
Page updated: April 15, 2020
Page reviewed: April 15, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external